TRACON PHARMACEUTICALS, INC. SEVERANCE PLAN SEVERANCE AGREEMENTSeverance Agreement • February 28th, 2020 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 28th, 2020 Company Industry JurisdictionThis Severance Agreement (the “Agreement”) is entered into effective December 4, 2019 (the “Effective Date”), by and between Scott Brown (“you” or “your”) and TRACON Pharmaceuticals, Inc. (the “Company”) pursuant to the TRACON Pharmaceuticals, Inc. Severance Plan (“Plan”). Capitalized terms used herein but not otherwise defined have the meanings set forth in the Plan.
EMPLOYMENT AGREEMENT For SCOTT BROWNEmployment Agreement • February 28th, 2020 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledFebruary 28th, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into effective as of January 28, 2020 (the “Effective Date”), by and between TRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Scott Brown (the “Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
COLLABORATION AND CLINICAL TRIAL AGREEMENTTrial Agreement • February 28th, 2020 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 28th, 2020 Company Industry JurisdictionThis Collaboration and Clinical Trial Agreement (the “Agreement”) is entered into on December 20, 2019 (the “Effective Date”) between 3D Medicines (Beijing) Co., Ltd., a company organized and existing under the laws of P.R.China and having its registered address at Suite 1201,Block B, Yicheng Fortune Center ,22 Ronghua Middle Road, BDA, Beijing, P.R. China (“3DMed”) Jiangsu Alphamab Biopharmaceuticals Co., Ltd., a company organized and existing under the laws of P.R. China and having its registered address at Building C23, 218 Xinghu Street, Suzhou, Jiangsu, P.R. China 215125 (“Jiangsu Alphamab”) (Jiangsu Alphamab and 3DMed collectively, “3DAlpha”), and Tracon Pharmaceuticals, Inc., a Delaware corporation, with its principal place of business at 4350 La Jolla Village Drive, Suite 800, San Diego, CA, USA (“Tracon”). Tracon, 3D, and Alphamab are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”